Should bisphosphonates be used for long-term treatment of glucocorticoid-induced osteoporosis?

Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate

(2010) Richard Eastell et al.   BONE

Perspectives bone histomorphometry in glucocorticoid-induced osteoporosis

(2010) David W. Dempster   JOURNAL OF BONE AND MINERAL RESEARCH

Relations between histologic indices of bone formation: Implications for the pathogenesis of spinal osteoporosis

(2010) A.M. Parfitt et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research

(2010) Elizabeth Shane et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Calpain-6, a target molecule of glucocorticoids, regulates osteoclastic bone resorption via cytoskeletal organization and microtubule acetylation

(2010) Jung Min Hong et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates

(2009) R. K. Dore et al.   ANNALS OF THE RHEUMATIC DISEASES

Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial

(2009) Kenneth G. Saag et al.   ARTHRITIS AND RHEUMATISM

Bone Turnover in Bone Biopsies of Patients with Low-Energy Cortical Fractures Receiving Bisphosphonates: A Case Series

(2009) Reina Armamento-Villareal et al.   CALCIFIED TISSUE INTERNATIONAL

Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy

(2009) David L Kendler et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Intravenous Bisphosphonate-Related Osteonecrosis of the Jaw: Bone Scintigraphy as an Early Indicator

(2009) Felice S. O'Ryan et al.   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Baseline Glucocorticoid Dose and Bone Mineral Density Response with Teriparatide or Alendronate Therapy in Patients with Glucocorticoid-induced Osteoporosis

(2009) J.-P. DEVOGELAER et al.   JOURNAL OF RHEUMATOLOGY

Bisphosphonates: Mechanism of Action and Role in Clinical Practice

(2009) Matthew T. Drake et al.   MAYO CLINIC PROCEEDINGS

Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: A longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice

(2008) Wei Yao et al.   ARTHRITIS AND RHEUMATISM

Atypical Fractures of the Femoral Diaphysis in Postmenopausal Women Taking Alendronate

(2008) Brett A. Lenart et al.   NEW ENGLAND JOURNAL OF MEDICINE